Zusammenfassung
Hintergrund
Mit steigender Zahl implantierter Herzschrittmacher und implantierbarer Kardioverter-Defibrillatoren (ICD) und einer steigenden Inzidenz von onkologischen Erkrankungen nimmt die Wahrscheinlichkeit für strahlungsbedingte Gerätestörungen zu. Die veröffentlichten Leitlinien zum Management von Schrittmacherpatienten stammen aus dem Jahr 1994 und sind seitdem nicht mehr aktualisiert worden. Auf Basis der aktuellen Evidenz und moderner Gerätetechnologie möchte die vorliegende Arbeit ein zeitgemäßes, interdisziplinäres Sicherheitsprotokoll zur Minimierung des Patientenrisikos entwickeln.
Methoden und Ergebnisse
Es wurde eine systematische Literaturrecherche in den wichtigsten medizinischen elektronischen Datenbanken durchgeführt. Für den Publikationszeitraum von 1994 bis 2012 ergab die Suche 147 Treffer, von denen 45 in die Bewertung eingeschlossen wurden. Primärdaten wurden von 34 Studien erhoben (9 In-vitro- und 25 In-vivo-Studien). Der Störeinfluss ionisierender Strahlung auf implantierte Geräte schwankte zwischen keinerlei Funktionsänderungen und komplettem Funktionsverlust. Relevante Fehlfunktionen beinhalteten eine Veränderung der Wahrnehmung, der Stimulationsleistung, gestörte Tachyarrhythmie-Therapien (bei ICDs), eine vorzeitige Batterieerschöpfung sowie einen Verlust der Telemetrie. Moderne Herzschrittmacher und ICDs sind strahlenempfindlicher als ältere Modelle. Potentiell lebensbedrohliche Zwischenfälle wurden bereits nach Exposition des Aggregats gegenüber relativ niedrigen Dosen beobachtet (0,11 Gy).
Schlussfolgerung
Es werden konkrete Sicherheitsempfehlungen zum Patientenmanagement vorgestellt, die ohne Weiteres von Einrichtungen, die strahlentherapeutische Leistungen anbieten, übernommen werden können.
Abstract
Background
With increasing numbers of implanted pacemakers and implantable cardioverter defibrillators (ICD) and a rising incidence of malignant tumors, there is a growing probability of radiation-mediated device dysfunction. The only guidelines for the management of patients with cardiac pacemakers in the case of radiation therapy were published in 1994 and have not been updated since then. Based on the current evidence and modern device technology, the present paper aims to develop contemporary and interdisciplinary safety recommendations for the minimization of patient risk.
Methods and results
A systematic literature research was carried out including the most relevant medical electronic databases. The search yielded 147 articles published between 1994 and 2012 of which 45 met the selection criteria and of these studies 34 presented primary data (9 in vitro and 25 in vivo studies). The impact of ionizing radiation varied significantly between implanted devices and ranged from no functional changes to complete loss of function. Important device dysfunctions included changes in sensing capability, altered pacing pulses or rate, changed or disabled tachyarrhythmia ICD therapies, early battery depletion and loss of telemetry. Modern pacemakers and ICDs are more sensitive to radiation than older models. Potentially life-threatening complications were observed after exposure of the pulse generator to comparatively low radiation doses (0.11 Gy).
Conclusions
Practical recommendations for patient management and safety are presented that can be readily adopted by any institution carrying out radiation therapy.
Literatur
Bamberg M, Budach W, Belka C, et al (1996) Radioonkologie 2000. Onkologe 2:5–9
Biotronik (2011) Strahlentherapie und Biotronik CRM-Implantate – Herzschrittmacher (IPG), Defibrillatoren (ICD) und CRT-Geräte. Berlin, Deutschland: Biotronik SE & Co. KG, Global Technical Service
Blank E, Willich N, Fietkau R et al (2012) Evaluation of time, attendance of medical staff, and resources during radiotherapy for breast cancer patients. The DEGRO-QUIRO trial. Strahlenther Onkol 188:113–119
Boston Scientific (2008) Therapeutische Bestrahlung und implantierbare Herzschrittmacher und Defibrillatoren. http://www.bostonscientific-international.com/templatedata/imports/HTML/CRM/pprc_intl/acl/de/pdfs/EMI/DE_ACL_Therapeutic_Radiation_121508.pdf
Croshaw R, Kim Y, Lappinen E et al (2011) Avoiding mastectomy: accelerated partial breast irradiation for breast cancer patients with pacemakers or defibrillators. Ann Surg Oncol 18:3500–3505
Dasgupta T, Barani IJ, Roach M III (2011) Successful radiation treatment of anaplastic thyroid carcinoma metastatic to the right cardiac atrium and ventricle in a pacemaker-dependent patient. Radiat Oncol 6:16
Dickstein K, Vardas PE, Auricchio A et al (2010) 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J 31:2677–2687
Dorenkamp M, Roser M, Hamm B et al (2012) Magnetic resonance imaging and implantable cardiac devices. Current status and future perspectives of MR-compatible systems. Herz 37:136–145
Ferrara T, Baiotto B, Malinverni G et al (2010) Irradiation of pacemakers and cardio-defibrillators in patients submitted to radiotherapy: a clinical experience. Tumori 96:76–83
Frantz S, Wagner J, Langenfeld H (2003) Radiation-induced pacemaker malfunction. Z Kardiol 92:415–417
Gelblum DY, Amols H (2009) Implanted cardiac defibrillator care in radiation oncology patient population. Int J Radiat Oncol Biol Phys 73:1525–1531
Gossman MS, Graves-Calhoun AR, Wilkinson JD (2009) Establishing radiation therapy treatment planning effects involving implantable pacemakers and implantable cardioverter-defibrillators. J Appl Clin Med Phys 11:3115
Gossman MS, Nagra B, Graves-Calhoun A et al (2011) Beam profile disturbances from implantable pacemakers or implantable cardioverter-defibrillator interactions. Med Dosim 36:358–364
Hashimoto T, Isobe T, Hashii H et al (2012) Influence of secondary neutrons induced by proton radiotherapy for cancer patients with implantable cardioverter defibrillators. Radiat Oncol 7:10
Hoecht S, Rosenthal P, Sancar D et al (2002) Implantable cardiac defibrillators may be damaged by radiation therapy. J Clin Oncol 20:2212–2213
Hudson F, Coulshed D, D’Souza E et al (2010) Effect of radiation therapy on the latest generation of pacemakers and implantable cardioverter defibrillators: a systematic review. J Med Imaging Radiat Oncol 54:53–61
Hurkmans CW, Scheepers E, Springorum BGF et al (2005) Influence of radiotherapy on the latest generation of pacemakers. Radiother Oncol 76:93–98
Hurkmans CW, Scheepers E, Springorum BGF et al (2005) Influence of radiotherapy on the latest generation of implantable cardioverter-defibrillators. Int J Radiat Oncol Biol Phys 63:282–289
John J, Kaye GC (2004) Shock coil failure secondary to external irradiation in a patient with implantable cardioverter defibrillator. Pacing Clin Electrophysiol 27:690–691
Kapa S, Fong L, Blackwell CR et al (2008) Effects of scatter radiation on ICD and CRT function. Pacing Clin Electrophysiol 31:727–732
Kesek M, Nyholm T, Asklund T (2012) Radiotherapy and pacemaker: 80 Gy to target close to the device may be feasible. Europace (Im Druck)
Kirova YM, Menard J, Chargari C et al (2012) Case study thoracic radiotherapy in an elderly patient with pacemaker: the issue of pacing leads. Med Dosim 37:192–194
Lambert P, Da Costa A, Marcy PY et al (2011) Pacemaker, implanted cardiac defibrillator and irradiation: management proposal in 2010 depending on the type of cardiac stimulator and prognosis and location of cancer. Cancer Radiother 15:238–249
Langer M, Orlandi E, Carrara M et al (2012) Management of patients with implantable cardioverter defibrillator needing radiation therapy for cancer. Br J Anaesth 108:881–882
Last A (1998) Radiotherapy in patients with cardiac pacemakers. Br J Radiol 71:4–10
Lau DH, Wilson L, Stiles MK et al (2008) Defibrillator reset by radiotherapy. Int J Cardiol 130:e37–e38
Little FA (1994) Pacemaker in radiotherapy. Clin Oncol 6:211–212
Lohr F, Baus W, Vorwerk H et al, für die AG Patientensicherheit der DEGRO/DGMP/VMTRO sowie für die ÖGRO/ÖGMP und SASRO/SGSMP (2012) Rules and regulations applying to incidents in radiotherapy. Strahlenther Onkol 188:545–550
Marbach JR, Sontag MR, Van Dyk J et al (1994) Management of radiation oncology patients with implanted cardiac pacemakers: report of AAPM Task Group No. 34. American Association of Physicists in Medicine. Med Phys 21:85–90
Medtronic (2000) Standardantworten zur Bestrahlung. http://www. medtronic.com/downloadablefiles/Standardantworten-Bestrahlung.pdf
Menard J, Campana F, Kirov KM et al (2011) Radiotherapy for breast cancer and pacemaker. Cancer Radiother 15:197–201
Mitra D, Ghosh K, Gupta P et al (2006) Radiation dose monitoring in a lung cancer patient with a pacemaker–a case report. Indian J Radiol Imaging 16:875–877
Momm F, Jooss D, Xander CJ et al (2011) Survey of potential improvements during the course of the radiotherapy treatment – a patient questionnaire. Strahlenther Onkol 187:750–756
Mouton J, Haug R, Bridier A et al (2002) Influence of high-energy photon beam irradiation on pacemaker operation. Phys Med Biol 47:2879–2893
Munshi A, Wadasadawala T, Sharma PK et al (2008) Radiation therapy planning of a breast cancer patient with in situ pacemaker – challenges and lessons. Acta Oncol 47:255–260
Nemec J (2007) Runaway implantable defibrillator – a rare complication of radiation therapy. Pacing Clin Electrophysiol 30:716–718
Nibhanupudy JR, Jesus MA de, Fujita M et al (2001) Radiation dose monitoring in a breast cancer patient with a pacemaker: a case report. J Natl Med Assoc 93:278–281
Oshiro Y, Sugahara S, Noma M et al (2008) Proton beam therapy interference with implanted cardiac pacemakers. Int J Radiat Oncol Biol Phys 72:723–727
Portaluri M, Fucilli FI, Gianicolo EA et al (2010) Collection and evaluation of incidents in a radiotherapy department: a reactive risk analysis. Strahlenther Onkol 186:693–699
Raitt MH, Stelzer KJ, Laramore GE et al (1994) Runaway pacemaker during high-energy neutron radiation therapy. Chest 106:955–957
Riley B, Garcia J, Guerrero T (2004) The utilization of a 3-dimensional noncoplanar treatment plan to avoid pacemaker complications. Med Dosim 29:92–96
Robert Koch-Institut (2012) Beiträge zur Gesundheitsberichterstattung des Bundes. Krebs in Deutschland 2007/2008. http://www.rki.de/Krebs/DE/Content/Publikationen/Krebs_in_Deutschland/kid_2012/krebs_in_deutschland_2012.pdf?__blob=publicationFile
Röthig H, Herrmann T, Kopcsek H (1995) Experience in dealing with artificial pacemaker patients during therapy with ionizing radiation. Strahlenther Onkol 171:398–402
Sepe S, Schaffer P, Krimmel K et al (2007) Irradiation treatment of laryngeal cancer in a patient with an implantable cardioverter-defibrillator (ICD). Onkologie 30:378–380
Soejima T, Yoden E, Nishimura Y et al (2011) Radiation therapy in patients with implanted cardiac pacemakers and implantable cardioverter defibrillators: a prospective survey in Japan. J Radiat Res 52:516–521
Solan AN, Solan MJ, Bednarz G et al (2004) Treatment of patients with cardiac pacemakers and implantable cardioverter-defibrillators during radiotherapy. Int J Radiat Oncol Biol Phys 59:897–904
Souliman SK, Christie J (1994) Pacemaker failure induced by radiotherapy. Pacing Clin Electrophysiol 17:270–273
St. Jude Medical (2002) Herstellerinformation Schrittmacher zu Strahlentherapie. http://www.sjm.de/media/2/D1003102/0279090312/Strahlen therapie.pdf
St. Jude Medical (2002) Herstellerinformation Defibrillator zu Bestrahlung. http://www.sjm.de/media/2/D1003102/0287091112/Bestrahlung.pdf
Sundar S, Symonds RP, Deehan C (2005) Radiotherapy to patients with artificial cardiac pacemakers. Cancer Treat Rev 31:474–486
Thomas D, Becker R, Katus HA et al (2004) Radiation therapy-induced electrical reset of an implantable cardioverter defibrillator device located outside the irradiation field. J Electrocardiol 37:73–74
Tondato F, Ng DW, Srivathsan K et al (2009) Radiotherapy-induced pacemaker and implantable cardioverter defibrillator malfunction. Expert Rev Med Devices 6:243–249
Tsekos A, Momm F, Brunner M et al (2000) The cardiac pacemaker patient – might the pacer be directly irradiated? Acta Oncol 39:881–883
Uiterwaal DJ, Springorum BGF, Scheepers E et al (2006) Interference detection in implantable defibrillators induced by therapeutic radiation therapy. Neth Heart J 14:330–334
Vardas PE, Auricchio A, Blanc JJ et al (2007) Guidelines for cardiac pacing and cardiac resynchronization therapy: the task force for cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 28:2256–2295
Wadasadawala T, Pandey A, Agarwal JP et al (2011) Radiation therapy with implanted cardiac pacemaker devices: a clinical and dosimetric analysis of patients and proposed precautions. Clin Oncol (R Coll Radiol) 23:79–85
Wilm M, Kronholz HL, Schütz J et al (1994) The modification of programmable pacemakers by therapeutic irradiation. Strahlenther Onkol 170:225–231
Wootton LS, Polf JC, Peterson S et al (2012) Proton dose perturbations caused by high-voltage leads from implanted cardioverter defibrillators. J Appl Clin Med Phys 13:3813
Zaremba T, Thøgersen AM, Eschen O et al (2010) High-dose radiotherapy exposure to cardiac pacemakers may be safe in selected patients. Radiother Oncol 95:133–134
Zweng A, Schuster R, Hawlicek R et al (2009) Life-threatening pacemaker dysfunction associated with therapeutic radiation: a case report. Angiology 60:509–512
Interessenkonflikt
Der korrespondierende Autor weist auf folgende Interessenkonflikte hin: W. Haverkamp hat Vortrags- und/oder Beraterhonorare von den Firmen Biotronik, Medtronic und St. Jude Medical erhalten. M. Roser hat Vortragshonorare von den Firmen Biotronik, Boston Scientific, Medtronic und St. Jude Medical erhalten. Die übrigen Autoren geben keine Interessenkonflikte an.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dorenkamp, M., Stromberger, C., von Heymann, C. et al. Strahlentherapie bei Patienten mit Herzschrittmachern oder implantierbaren Kardioverter-Defibrillatoren. Strahlenther Onkol 189, 5–17 (2013). https://doi.org/10.1007/s00066-012-0243-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-012-0243-8
Schlüsselwörter
- Implantierbare Kardioverter-Defibrillatoren
- Ionisierende Strahlung
- Elektromagnetische Interferenz
- Interdisziplinäres Gesundheitsteam
- Krankheitsmanagement